The mammalian mineralocorticoid receptor: tying down a promiscuous receptor
- PMID: 19648477
- PMCID: PMC3140538
- DOI: 10.1113/expphysiol.2008.045914
The mammalian mineralocorticoid receptor: tying down a promiscuous receptor
Abstract
The mineralocorticoid receptor (MR) has been called a promiscuous receptor because its intrinsic affinity for aldosterone, cortisol and corticosterone is similar. Since glucocorticoids circulate in concentrations 100- to 1000-fold those of aldosterone, stoichiometry dictates that MR should be activated by glucocorticoids, not aldosterone, yet MRs are expressed in many tissues and regulate diverse functions, many of them under the regulation of the renin-angiotensin-aldosterone system. A relatively small number of brain MRs are aldosterone selective and modulate blood pressure. Evidence for possible mechanisms conferring ligand specificity in the context of mineralocorticoid-induced hypertension and the brain are discussed. These include factors (or mechanisms) intrinsic to the receptor, such as alternative splice variants and translation start sites, and extrinsic to the MR, including differential access through the blood-brain barrier, differential recruitment of co-regulators and scaffolding proteins, 11beta-steroid dehydrogenase activity, synthesis of potent acylated aldosterone derivatives and the synthesis of relevant amounts of aldosterone in areas of the brain that modulate blood pressure.
Comment in
-
Adrenal corticosteroid effects in the central nervous system on long-term control of blood pressure.Exp Physiol. 2010 Jan;95(1):10-2. doi: 10.1113/expphysiol.2008.045484. Exp Physiol. 2010. PMID: 20064826 Free PMC article. No abstract available.
Similar articles
-
The ubiquitous mineralocorticoid receptor: clinical implications.Curr Hypertens Rep. 2012 Dec;14(6):573-80. doi: 10.1007/s11906-012-0297-0. Curr Hypertens Rep. 2012. PMID: 22843494 Free PMC article. Review.
-
Stimulation of testosterone production in rat Leydig cells by aldosterone is mineralocorticoid receptor mediated.Mol Cell Endocrinol. 2005 Nov 24;243(1-2):35-42. doi: 10.1016/j.mce.2005.08.004. Epub 2005 Sep 26. Mol Cell Endocrinol. 2005. PMID: 16188378
-
An in Vitro triple screen model for human mineralocorticoid receptor activity.J Steroid Biochem Mol Biol. 2024 Oct;243:106568. doi: 10.1016/j.jsbmb.2024.106568. Epub 2024 Jun 10. J Steroid Biochem Mol Biol. 2024. PMID: 38866188
-
Role of mineralocorticoid action in the brain in salt-sensitive hypertension.Clin Exp Pharmacol Physiol. 2012 Jan;39(1):90-5. doi: 10.1111/j.1440-1681.2011.05538.x. Clin Exp Pharmacol Physiol. 2012. PMID: 21585422 Free PMC article. Review.
-
Towards selectively modulating mineralocorticoid receptor function: lessons from other systems.Mol Cell Endocrinol. 2004 Mar 31;217(1-2):151-65. doi: 10.1016/j.mce.2003.10.044. Mol Cell Endocrinol. 2004. PMID: 15134814 Review.
Cited by
-
Central regulation of blood pressure by the mineralocorticoid receptor.Mol Cell Endocrinol. 2012 Mar 24;350(2):289-98. doi: 10.1016/j.mce.2011.05.005. Epub 2011 Jun 1. Mol Cell Endocrinol. 2012. PMID: 21664417 Free PMC article. Review.
-
Mineralocorticoid receptors in the brain and cardiovascular regulation: minority rule?Trends Endocrinol Metab. 2011 May;22(5):179-87. doi: 10.1016/j.tem.2011.02.001. Epub 2011 Mar 21. Trends Endocrinol Metab. 2011. PMID: 21429762 Free PMC article. Review.
-
Negative effects of chlorthalidone on sympathetic nervous system and insulin resistance in hypertensive patients may be avoided with spironolactone: further studies are still needed.Ir J Med Sci. 2015 Dec;184(4):727-9. doi: 10.1007/s11845-015-1350-1. Epub 2015 Sep 4. Ir J Med Sci. 2015. PMID: 26341505 Review.
-
The ubiquitous mineralocorticoid receptor: clinical implications.Curr Hypertens Rep. 2012 Dec;14(6):573-80. doi: 10.1007/s11906-012-0297-0. Curr Hypertens Rep. 2012. PMID: 22843494 Free PMC article. Review.
-
Stress and glucocorticoids increase transthyretin expression in rat choroid plexus via mineralocorticoid and glucocorticoid receptors.J Mol Neurosci. 2012 Sep;48(1):1-13. doi: 10.1007/s12031-012-9715-7. Epub 2012 Feb 28. J Mol Neurosci. 2012. PMID: 22371232
References
-
- Arriza JW, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science. 1987;237:268–275. - PubMed
-
- Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A. Hexose-6-phosphate dehydrogenase determines the reaction direction of 11beta-hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett. 2004;571:129–133. - PubMed
-
- Birmingham MK, Sar M, Stumpf WE. Localization of aldosterone and corticosterone in the central nervous system, assessed by quantitative autoradiography. Neurochem Res. 1984;9:333–350. - PubMed
-
- Brody MJ, Varner KJ, Vasquez EC, Lewis SJ. Central nervous system and the pathogenesis of hypertension. Sites and mechanisms. Hypertension. 1991;18:III7–III12. - PubMed
-
- Connell JM, Davies E. The new biology of aldosterone. J Endocrinol. 2005;186:1–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources